Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response.
Nine patients with advanced Hodgkin's lymphoma (HL) who had undergone allogeneic stem cell transplantation (allo-SCT) received donor leukocyte infusions (DLIs) for treatment of persistent or progressive disease (PD). A total of 15 DLIs were performed, with four patients receiving more than one DLI. In four patients, prior salvage chemotherapy was administered. The median CD3+ cell dose administered was 77.5 x 10(6)/kg (range 5-285). GVHD developed in all but one patient. The response rate was 4/9 (44%). Three of these four responders developed GVHD and 3/4 had received chemotherapy. No correlation was observed between CD3+ cell dose infused and disease response. At the latest follow-up, three patients are alive and six have expired (PD n=3, nonrelapse mortality n=3). The median response duration was 7 months (range 4-9), with one response currently ongoing. These data suggest that DLIs for immunotherapy of recurrent HL have significant activity, although they frequently leads to GVHD. The small sample size does not allow any conclusion as to whether chemotherapy administration increases the chance of response. The CD3 cell dose infused does not seem to correlate with disease response.
Anderlini
P
P
Department of Blood and Marrow Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. panderli@mdanderson.org
Acholonu
S A
SA
Okoroji
G-J
GJ
Andersson
B S
BS
Couriel
D R
DR
De Lima
M J
MJ
Donato
M L
ML
Khouri
I F
IF
Giralt
S A
SA
Ueno
N T
NT
Champlin
R E
RE
D000293:Adolescent; D000328:Adult; D015703:Antigens, CD / Q000097:blood; D017252:CD3 Complex / Q000097:blood; D006086:Graft vs Host Disease / Q000628:therapy*; D020350:Graft vs Tumor Effect / Q000502:physiology*; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D017710:Lymphocyte Transfusion; D012008:Recurrence; D012189:Retrospective Studies; D033581:Stem Cell Transplantation; D014019:Tissue Donors; D014184:Transplantation, Homologous / Q000502:physiology
D015703:Antigens, CD; D017252:CD3 Complex